Digital-Deal Alignment: Considerations for Tech Agreements
Published: | Updated:
The eight key areas biopharma manufacturers must stay on top of when planning and executing alliance agreements with prospective digital health partners.
Emily Lowe, Michele Buenafe, and Kelli Boyle
Advertisement
Emily Lowe, Michele Buenafe, and Kelli Boyle — Morgan, Lewis & Bockius LLP.
Articles by Emily Lowe, Michele Buenafe, and Kelli Boyle
Advertisement
Latest Updated Articles
Digital-Deal Alignment: Considerations for Tech AgreementsPublished: May 13th 2021 | Updated: July 8th 2021
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Hernexeos Under National Priority Voucher Program
2
Pharmaceutical Executive Daily: FDA Approves Hernexeos
3
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
4
What Does the Rollout of Trump Rx Reveal?
5